Survival of patients with thyroid carcinoma by patient demographics and tumor characteristics
| Percentage Total | 10-Year Relative Survival (%) | 95% CI | 10-Year Thyroid Cancer–Specific Survival (%) | 95% CI | |
|---|---|---|---|---|---|
| Total | 100% | 97.4 | 97.0–97.7 | 95.7 | 95.5–95.9 |
| Sex | |||||
| Male | 23% | 93.8 | 92.9–94.7 | 92.0 | 91.4–92.5 |
| Female | 77% | 98.4 | 98.0–98.6 | 96.8 | 96.6–97.0 |
| Age (yr) | |||||
| 0–19 | 2.2% | 99.1 | 98.3–99.5 | 99.3 | 98.7–99.6 |
| 20–34 | 21% | 99.3 | 98.9–99.5 | 99.7 | 99.5–99.8 |
| 35–49 | 36% | 99.3 | 98.9–99.5 | 98.9 | 98.7–99.0 |
| 50–64 | 27% | 96.2 | 95.3–96.9 | 94.6 | 94.1–95.1 |
| ≥65 | 15% | 90.3 | 88.1–92.1 | 81.0 | 79.9–82.0 |
| SEER summary stage | |||||
| Localized or unstaged | 61% | 99.9 | 99.8–99.9 | 99.0 | 98.9–99.1 |
| Regional | 35% | 95.6 | 95.0–96.2 | 94.4 | 94.0–94.8 |
| Distant | 4.1% | 56.1 | 53.5–58.5 | 58.2 | 56.0–60.4 |
| Tumor size (mm) | |||||
| <5 | 12% | 99.9 | 99.7–99.9 | 99.4 | 99.0–99.6 |
| 5–10 | 14% | 99.8 | 99.6–99.9 | 98.9 | 98.6–99.2 |
| 10–14 | 15% | 99.8 | 99.5–99.9 | 99.0 | 98.7–99.2 |
| 15–19 | 13% | 99.8 | 99.5–99.9 | 98.3 | 97.9–98.6 |
| 20–29 | 20% | 99.4 | 98.3–99.8 | 97.0 | 96.7–97.4 |
| 30–39 | 11% | 96.6 | 95.5–97.4 | 95.2 | 94.6–95.7 |
| ≥40 | 14% | 84.0 | 82.7–85.2 | 83.3 | 82.4–84.2 |